Stockreport

Recro Pharma’s Board of Directors Approves Separation of Acute Care Business Segment and Declares Special Dividend Distribution of Baudax Bio Common Stock

Recro Pharma, Inc.  (REPH) 
Last recro pharma, inc. earnings: 11/8 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.recropharma.com
PDF MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a specialty pharmaceutical company with a high-performing revenue generating contract [Read more]